conference call van Paion:
And of course, finally, a very important launch in the U.S. market this -- we can't give you an exact date for because Acacia Pharma, our partner, are working with the DEA, so the Drug Enforcement Agency, to get the drug scheduled, which is a critical part of the work prior to launch, and then we would expect launch probably in the early part of Q4.
Dus das volgende maand, tussen labeling DEA en launch moeten er nog wat zaken gebeuren ( de prescriptie laten goedkeuren, drukwerk...). Dus volgens mij hebben ze al DEA antwoord.